April 2015 FDA Recall Acarbose by Boehringer Ingelheim Roxane Inc
D-1085-2015 - Subpotent Drug

This Class II drug recall was voluntarily initiated by Boehringer Ingelheim Roxane Inc on April 2, 2015 for the product Acarbose. The FDA reported the reason for recall as subpotent drug. The product was distributed Nationwide and the recall is currently completed.

Recall Number: D-1085-2015

Reason for Recall
Subpotent Drug: The firm received an out of specification result for Assay (potency was below specification) at the 9 month stability time point.
Initiated
04-02-2015
Reported
06-03-2015
Quantity
a) 575 Blister Packs, b) 12,802 Bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Boehringer Ingelheim Roxane Inc
Nationwide and Puerto Rico
Acarbose Tablets 50 mg a)10 x 10 Unit Dose Tablets per Blister Pack, b)100 count Bottles, Rx only, Roxane Laboratories, Inc. Columbus, Ohio 43216, NDC a) 0054-0141-20, b) 0054-0141-25

Batch or Lot Expiration Information

Lot# a)
Lot# 460073A Exp 04/2016 b)
Lot# 460073B Exp 04/2016